You are here
May 10, 2014
Ian Read, Chairman and CEO of Pfizer, discusses a potential combination with AstraZeneca
Ian Read AstraZeneca Announcement
Question 1 – Why is Pfizer interested in a combination with AstraZeneca? Why AstraZeneca? What are the main benefits for shareholders and other stakeholders?
Question 2 - What is the motivation for the potential combination?
Question 3 How would you accomplish a large scale integration, should you be successful?